Rafferty Asset Management, LLC Praxis Precision Medicines, Inc. Transaction History

Rafferty Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.75 - $11.34 $279,357 - $1.81 Million	159,633 Added 227.37%	229,840 $563,000
Q1 2022 May 13, 2022	BUY	$10.21 - $20.29 $27,730 - $55,107	2,716 Added 4.02%	70,207 $717,000
Q4 2021 Feb 10, 2022	BUY	$16.76 - $22.99 $1.13 Million - $1.55 Million	67,491 New	67,491 $1.33 Million
Q2 2021 Aug 10, 2021	SELL	$18.28 - $33.05 $687,218 - $1.24 Million	-37,594 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$29.34 - $60.2 $1.1 Million - $2.26 Million	37,594 New	37,594 $1.23 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.